Vysera-CLS
Bremenn Clinical Vysera-CLS is a multi-ingredient supplement categorized under 'Other Combinations,' featuring five distinct components. Per one-capsule serving, it includes 56mg Vitamin B3 and 50mcg Chromium, both present at clinically studied dosages. However, the 36mg of Calcium is underdosed compared to typical recommendations for bone health. The product also contains proprietary blends for weight control and energy/focus/mood, which lack specific ingredient transparency. Attaining an N+ Score of 70 and a 'C' grade, this product offers some clinically dosed vitamins but has limitations in its mineral content and proprietary blend disclosure. It may appeal to those seeking a multi-faceted supplement with some transparently dosed ingredients.
About This Product
Vysera-CLS by Bremenn Clinical is a joint & bone supplement containing 5 active ingredients. It has earned an N+ Score of 70/100 (Grade C).
Notable clinical-dose ingredients include Chromium, Vitamin B3.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +2 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (5 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calcium | 36.000 mg | Under |
| Chromium | 50.000 mcg | Optimal |
| Vitamin B3 | 56.000 mg | High |
| Proprietary Weight Control Component: | 142.000 mg | N/A |
| Proprietary Energy/Focus/Mood Component: | 115.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.